Five international healthtech startups have made it to the final phase of DayOne Health 4.0. With this accelerator, DayOne, the initiative of Basel Area Business & Innovation, aims to promote solutions that focus on artificial intelligence, data and clinical development.
The selection committee has chosen five healthtech startups for the second and final phase of the six-month DayOne Health 4.0 accelerator programme: Briya from Israel, CliniNote from Poland, FindMeCure from Bulgaria, InSilicoTrials Technologies from Italy and machineMD from Switzerland. DayOne is an initiative of Basel Area Business & Innovation, the investment and innovation promotion agency. It is doing pioneering work for the future of healthcare.
The thematic focus of this edition of the accelerator, which began in September 2023 and ends in March 2024, is artificial intelligence (AI), data and digitally improved clinical development. It received a total of 109 applications from 35 countries. Fifteen of the applications had passed Phase 1 by mid-November. According to the jury, the five projects that have now been selected offer a strong value proposition, made significant progress in phase 1 of the programme, and are ready to engage in collaborations, particularly with biopharmaceutical companies.
